<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20251027067779N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2026-06-27</date_registration>
      <primary_sponsor>Shahid Beheshti University of Medical Sciences</primary_sponsor>
      <public_title>Education program on adherence of stroke patient and perceived stress of caregivers</public_title>
      <acronym></acronym>
      <scientific_title>Comparison of telehealth and in-person discharge education program on adherence of stroke patient and perceived stress of caregivers</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2026-08-23</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>70</target_size>
      <recruitment_status>Recruiting</recruitment_status>
      <url>https://irct.ir/trial/87066</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Single blinded, Placebo: Not used, Assignment: Parallel, Purpose: Supportive, Randomization description: Random block sampling will be carried out in two groups: telehealth and face-to-face learning. The random assignment sequence and block list will be obtained by the statistical consultant using R software. The number of people assigned to each group is 35. In this method, the desired blocks of four are formed. Initially, 20 blocks of four are identified and A (face-to-face learning) and B (telehealth group) are determined.The samples are then randomly assigned to groups at consecutive intervals according to blocks selected from 20 prepared blocks. For example, after randomly selecting a block such as the ABAB block, patients are randomly assigned to the face-to-face, telehealth, face-to-face, and telehealth groups. After creating the random sequence, sampling must be done by concealing the created sequence. In such a way that the assigned group for the samples is not known before the individual is assigned. This is done by placing the random sequence inside an envelope and selecting an opaque envelope. At the time of participant registration, based on the order in which the eligible samples enter the study, one of the envelopes is opened in order and the assigned group of that participant is revealed. The code of each patient will also be assigned to his or her family member. Individuals are randomly assigned to the desired group through the randomized blocks in the order in which they enter the study, Blinding description: This research is single-blind due to the nature of the intervention, which is education and is presented in two ways. Both the researcher and the samples know which group they are placed in, and only the data analyst is unaware of the group assignment.</study_design>
      <phase>N/A</phase>
      <hc_freetext>سکته مغزی ایسکمیک.</hc_freetext>
      <i_freetext>Intervention 1: The first intervention group: Face-to-face education during discharge for stroke patients and their caregivers. The education program will include three 30- to 40-minute sessions (one individual session and two group sessions including groups of 3 to 5 people) about the definition of stroke, the importance of continuing treatment, the level of adherence to the medication adherence program, and the importance of medications, the problems of stroke patients (special diet plan for patients with swallowing disorders, motor rehabilitation and speech therapy program), principles of preventing recurrence and team structure for treatment (the importance of family presence with the patient and interaction in the educational program, the importance of playing the role of the patient and family in various sessions and the patient's treatment and care plan), and daily care of stroke patients and preventing recurrence, including education on recommendations to prevent recurrence of stroke (anger control, control of stressful stimuli, proper nutrition, medication and care adherence) and education on the causes of recurrence (non-compliance with the medication and care plan, lack of cooperation of the family in the patient's treatment and care process, lack of cooperation of the patient with the treatment staff, and non-compliance with the treatment and medication plans). Intervention 2: Intervention group: The second intervention group:telehealth education during discharge for stroke patients and their families. Virtual education will be provided through the provision of virtual educational content (offline) in a channel created in one of the internal messaging platforms agreed upon by the patients. The content of the education program will be sent by sending three educational videos or audio files along with PDFs (each video 30 minutes) within a week, at the beginning of the week, three days later, and at the end of the week. In case of any questions or uncertainties, the patient and their companions will be given a phone number to call.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
Participants data file

When:
One year after the publication of the article

To whom:
Researchers working in academic and scientific institutions

Conditions:
Data will be made available upon request for secondary studies.

Where to obtain:
Responsible author of the article
nedasanaie@ymail.com

How to obtain:
After sending an email to the responsible person and evaluating the type and reason, the requested documents are sent.

Comments:
</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Neda Sanaie</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Tehran, Vali Asr Street, Ayatollah Hashemi Rafsanjani Highway Intersection, in front of Shahid Rajaee Heart Hospital, Faculty of Nursing and Midwifery.</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>1996835119</zip>
        <telephone>88644549</telephone>
        <email>nedasanaei1986@gmail.com</email>
        <affiliation>Shahid Beheshti University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Neda Sanaei</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Tehran, Vali Asr Street, Ayatollah Hashemi Rafsanjani Highway Intersection, in front of Shahid Rajaee Heart Hospital, Faculty of Nursing and Midwifery.</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>1996835119</zip>
        <telephone>70-88655366</telephone>
        <email>nedasanaei1986@gmail.com</email>
        <affiliation>Shahid Beheshti University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Be literate in reading and writing.
Be able to communicate
Be responsible for the first experience of caring for a stroke patient.
Family members as spouses or other adults who are responsible for the patient's care, or who are more involved in the patient's care issues and problems than other family members, or who provide care to the patient at least twice a week and are willing to participate in the study.
The age range of people is between 18 and 70 years.
Willingness to participate in research
Hospitalization in the neurology department of hospitals affiliated with Shahid Beheshti University of Medical Sciences
Patient is alert, aware of time, place, and person, and trainable.
The patient has not received thrombolytic medication and is hospitalized due to complications from the stroke.</inclusion_criteria>
      <agemin>18 years</agemin>
      <agemax>70 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Having known physical or mental illnesses that affect quality of life, such as dialysis, or other known mental problems, such as depression and schizophrenia, that require medication or a specific diet (according to patient self-report).
People who participated in another training program during the research.
The caregiver is caring for a patient other than the stroke patient.
The caregiver has a known mental or neurological disorder (according to self-report).
Take care of members of the medical and healthcare staff.</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>Z55.8</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Other problems related to education and literacy</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Behavior</i_code>
      <i_code>Behavior</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>The first intervention group: Face-to-face education during discharge for stroke patients and their caregivers. The education program will include three 30- to 40-minute sessions (one individual session and two group sessions including groups of 3 to 5 people) about the definition of stroke, the importance of continuing treatment, the level of adherence to the medication adherence program, and the importance of medications, the problems of stroke patients (special diet plan for patients with swallowing disorders, motor rehabilitation and speech therapy program), principles of preventing recurrence and team structure for treatment (the importance of family presence with the patient and interaction in the educational program, the importance of playing the role of the patient and family in various sessions and the patient's treatment and care plan), and daily care of stroke patients and preventing recurrence, including education on recommendations to prevent recurrence of stroke (anger control, control of stressful stimuli, proper nutrition, medication and care adherence) and education on the causes of recurrence (non-compliance with the medication and care plan, lack of cooperation of the family in the patient's treatment and care process, lack of cooperation of the patient with the treatment staff, and non-compliance with the treatment and medication plans).</i_keyword>
      <i_keyword>Intervention group: The second intervention group:telehealth education during discharge for stroke patients and their families. Virtual education will be provided through the provision of virtual educational content (offline) in a channel created in one of the internal messaging platforms agreed upon by the patients. The content of the education program will be sent by sending three educational videos or audio files along with PDFs (each video 30 minutes) within a week, at the beginning of the week, three days later, and at the end of the week. In case of any questions or uncertainties, the patient and their companions will be given a phone number to call.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Treatment adherence of stroke patients. Timepoint: Post-discharge education will be provided in the form of 2-3 30-minute training sessions, in person and online, and data will be collected according to the treatment plan before and eight weeks after the completion of the intervention, and the results will be compared. Method of measurement: In the study, a comparison of distance and face-to-face education during discharge on treatment adherence of stroke patients will be conducted, and to examine this variable, the Medanlou Treatment Adherence Questionnaire will be used, which includes 40 questions and 7 subscales. The scope of attention in treatment includes 9 questions, willingness to participate in treatment includes 7 questions, ability to adapt treatment to life includes 7 questions, integration of treatment with life includes 5 questions, insistence on treatment includes 4 questions, commitment to treatment includes 5 questions, and measures in implementing treatment includes 3 questions. The measurement scale in this questionnaire is a 6-part Likert scale, which is designed from completely with a score of 5 to not at all with a score of zero, and the minimum score is zero and the maximum is 200.</prim_outcome>
      <prim_outcome>Caregivers' Perceived Stress Questionnaire. Timepoint: Post-discharge education will be provided in the form of 2-3 30-minute training sessions, both in person and online, and data on perceived stress will be collected before and eight weeks after the completion of the intervention, and the results will be compared. Method of measurement: To assess caregivers' perceived stress, the Perceived Stress Questionnaire was developed by Cohen et al., 1983. This scale has 14 items with a five-point Likert scale, from never to very much, and each item has a value between 0 and 4, with questions such as: During the past month, to what extent have you been upset because of a problem that you did not expect? During the past month, to what extent have you felt that your problems have piled up so much that you cannot cope with them? It measures perceived stress and is a single-component scale. The minimum possible score is 0 and the maximum is 56. A score between 0 and 18: the level of perceived stress is low, a score between 18 and 36: medium, and a score above 36: high.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Shahid Beheshti University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2026-02-17</approval_date>
        <contact_name>Ethics Committee of Shahid Beheshti Medical Sciences School of Nursing and Midwifery</contact_name>
        <contact_address>Tehran, Vali Asr Street, Ayatollah Hashemi Rafsanjani Highway Intersection, in front of Shahid Rajaee Heart Hospital, Faculty of Nursing and Midwifery tehran Tehran Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
